HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hematometra complicating hormone replacement therapy after radiation for cervical carcinoma.

Abstract
Hematometra developed in a patient receiving sequential estrogen-progestogen hormone replacement therapy following radiation for cervical carcinoma. Diagnosis, treatment and therapeutic recommendations are discussed.
AuthorsM V Sauer, M Tomlinson, W Rich
JournalArchives of gynecology and obstetrics (Arch Gynecol Obstet) Vol. 243 Issue 4 Pg. 235-6 ( 1988) ISSN: 0932-0067 [Print] Germany
PMID2851962 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Estrogens, Conjugated (USP)
  • Medroxyprogesterone
Topics
  • Carcinoma, Squamous Cell (drug therapy, radiotherapy)
  • Drug Therapy, Combination
  • Estrogens, Conjugated (USP) (adverse effects)
  • Female
  • Hematometra (chemically induced)
  • Humans
  • Medroxyprogesterone (adverse effects)
  • Middle Aged
  • Uterine Cervical Neoplasms (drug therapy, radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: